Published in Nucleic Acids Res on February 15, 1996
Inducible alkylation of DNA by a quinone methide-peptide nucleic acid conjugate. Biochemistry (2012) 0.81
Trioligonucleotide reagents: addressed RNA modification. Dokl Biochem Biophys (2010) 0.75
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Sequence-specific photo-induced cross-linking of the two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide. Proc Natl Acad Sci U S A (1991) 2.40
Complementary-addressed (sequence-specific) modification of nucleic acids. Prog Nucleic Acid Res Mol Biol (1985) 1.87
The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des (1991) 1.81
Hybridization triggered cross-linking of deoxyoligonucleotides. Nucleic Acids Res (1986) 1.69
CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents. Proc Natl Acad Sci U S A (1995) 1.51
Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. Science (1984) 1.44
Solution hybridization of crosslinkable DNA oligonucleotides to bacteriophage M13 DNA. Effect of secondary structure on hybridization kinetics and equilibria. J Mol Biol (1987) 1.43
Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry (1985) 1.37
Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity. Bioorg Med Chem (1994) 1.30
Sequence selectivity of DNA covalent modification. Chem Res Toxicol (1992) 1.28
Sequence-specific crosslinking agents for nucleic acids. Use of 6-bromo-5,5-dimethoxyhexanohydrazide for crosslinking cytidine to guanosine and crosslinking RNA to complementary sequences of DNA. J Mol Biol (1978) 1.24
Chemistry of thermal degradation of abasic sites in DNA. Mechanistic investigation on thermal DNA strand cleavage of alkylated DNA. Chem Res Toxicol (1995) 1.12
The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic. J Antibiot (Tokyo) (1986) 1.02
Structure of the (+)-CC-1065-DNA adduct: critical role of ordered water molecules and implications for involvement of phosphate catalysis in the covalent reaction. Biochemistry (1991) 0.97
Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065. J Med Chem (1988) 0.95
Sequence-specific covalent modification of DNA by cross-linking oligonucleotides. Catalysis by RecA and implication for the mechanism of synaptic joint formation. Biochemistry (1995) 0.94
[Epidemiological analysis of the influenza virus A carrier state in healthy children]. Vopr Virusol (1983) 0.89
An efficient, sequence-specific method for crosslinking complementary oligonucleotides using binuclear platinum complexes. Nucleic Acids Res (1991) 0.88
Hybridization of a complementary ribooligonucleotide to the transcription start site of the lacUV-5-Escherichia coli RNA polymerase open complex. Potential for gene-specific inactivation reagents. Biochemistry (1994) 0.87
Factors influencing the extent and regiospecificity of cross-link formation between single-stranded DNA and reactive complementary oligodeoxynucleotides. Biochemistry (1994) 0.87
(+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts. Chem Res Toxicol (1991) 0.85
Target-promoted alkylation of DNA. Bioconjug Chem (1995) 0.80
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res (2000) 5.24
Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry. Annu Rev Biochem (1985) 4.83
A topological model for transcription based on unwinding angle analysis of E. coli RNA polymerase binary, initiation and ternary complexes. Cell (1982) 3.58
Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res (1997) 2.29
Use of psoralen-modified oligonucleotides to trap three-stranded RecA-DNA complexes and repair of these cross-linked complexes by ABC excinuclease. J Biol Chem (1988) 1.55
Facile preparation of nuclease resistant 3' modified oligodeoxynucleotides. Nucleic Acids Res (1993) 1.51
Oligodeoxyribonucleotides with conjugated dihydropyrroloindole oligopeptides: preparation and hybridization properties. Bioconjug Chem (1995) 1.45
Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents. Biochemistry (1996) 1.42
Sequence-specific arrest of primer extension on single-stranded DNA by an oligonucleotide-minor groove binder conjugate. Proc Natl Acad Sci U S A (1996) 1.35
Oligonucleotides with conjugated dihydropyrroloindole tripeptides: base composition and backbone effects on hybridization. Nucleic Acids Res (1997) 1.32
Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci (1974) 1.27
Induction of hepatic tyrosine aminotransferase in vivo by derivatives of cyclic adenosine 3':5'-monophosphate. J Biol Chem (1975) 1.16
Reverse Southern hybridization. Nucleic Acids Res (1986) 1.16
Electromechanical Fredericks effects in nematic gels. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 1.16
2' Derivatives of guanosine and inosine cyclic 3',5'-phosphates. Synthesis, enzymic activity, and the effect of 8-substituents. Biochemistry (1976) 1.13
G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties. Nucleic Acids Res (1996) 1.11
Triplex targeting of a native gene in permeabilized intact cells: covalent modification of the gene for the chemokine receptor CCR5. Nucleic Acids Res (1998) 1.03
Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Res (1998) 1.03
DNA strand scission by benzo[a]pyrene diol epoxides. Science (1977) 1.01
Acridine- and cholesterol-derivatized solid supports for improved synthesis of 3'-modified oligonucleotides. Bioconjug Chem (1992) 1.00
Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid. Antimicrob Agents Chemother (1977) 1.00
Direct, solid phase assembly of dihydropyrroloindole peptides with conjugated oligonucleotides. Bioconjug Chem (1997) 0.99
Complementary addressed modification and cleavage of a single stranded DNA fragment with alkylating oligonucleotide derivatives. Nucleic Acids Res (1986) 0.98
Oligonucleotides complementary to a promoter over the region -8...+2 as transcription primers for E. coli RNA polymerase. Nucleic Acids Res (1984) 0.97
Synthesis and high stability of complementary complexes of N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides. Bioconjug Chem (1992) 0.95
Sequence-specific covalent modification of DNA by cross-linking oligonucleotides. Catalysis by RecA and implication for the mechanism of synaptic joint formation. Biochemistry (1995) 0.94
Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors. J Am Chem Soc (1976) 0.94
Size of the unwound region of DNA in Escherichia coli RNA polymerase and calf thymus RNA polymerase II ternary complexes. Cold Spring Harb Symp Quant Biol (1983) 0.91
Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex-directed covalent modification of the template strand. Biochemistry (1999) 0.90
DNA alkylation and unwinding induced by benzo[a]pyrene diol epoxide: modulation by ionic strength and superhelicity. Proc Natl Acad Sci U S A (1980) 0.89
Factors influencing the extent and regiospecificity of cross-link formation between single-stranded DNA and reactive complementary oligodeoxynucleotides. Biochemistry (1994) 0.87
Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). J Med Chem (1978) 0.87
Inhibition of tRNA aminoacylation by 2'-O-methyl oligonucleotides. Biochemistry (1996) 0.87
Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates. Bioconjug Chem (1998) 0.87
2,5-Anhydro-1-deoxy-1-phosphono-D-altritol, an isosteric analogue of alpha-D-ribofuranose 1-phosphate. J Med Chem (1984) 0.87
Mutagenesis induced by site specifically placed 4'-hydroxymethyl-4,5',8-trimethylpsoralen adducts. Nucleic Acids Res (1988) 0.86
Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides. Nucleic Acids Res (1997) 0.86
An improved CPG support for the synthesis of 3'-amine-tailed oligonucleotides. Bioconjug Chem (1992) 0.86
Studies of the functional topography of Escherichia coli RNA polymerase. Affinity labelling of RNA polymerase in a promoter complex by phosphorylating derivatives of primer oligonucleotides. Eur J Biochem (1987) 0.85
Synthesis and biological activity of several 6-substituted 9- -D-ribofuranosylpurine 3',5',-cyclic phosphates. Biochemistry (1972) 0.85
Synthesis, intramolecular hydrogen bonding, and biochemical studies of clitocine, a naturally occurring exocyclic amino nucleoside. J Med Chem (1988) 0.85
RecA-catalyzed, sequence-specific alkylation of DNA by cross-linking oligonucleotides. Effects of length and nonhomologous base substitutions. Biochemistry (1996) 0.84
Preparation and hybridization properties of oligonucleotides containing 1-alpha-D-arabinofuranosylthymine. Nucleic Acids Res (1991) 0.83
Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines. J Med Chem (1980) 0.82
Nucleosides of 1,4-thiazin-3-one and derivatives as tetrahedral intermediate analogues of enzymes in pyrimidine nucleoside metabolism. J Med Chem (1988) 0.81
In vitro antiviral activity of 6-substituted 9-beta-D-ribofuranosylpurine 3', 5'-cyclic phosphates. Antimicrob Agents Chemother (1974) 0.81
Benzo(alpha)pyrene effects on mouse epithelial cells in culture. Cancer Res (1975) 0.81
N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides as effectors of the sequence-specific modification of nucleic acids with reactive oligonucleotide derivatives. FEBS Lett (1988) 0.81
Design and synthesis of tetrahedral intermediate analogues as potential dihydroorotase inhibitors. J Med Chem (1984) 0.81
Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin. J Biol Chem (1999) 0.81
Synthesis and enzymatic and inotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3',5'-monophosphate. J Med Chem (1980) 0.80
Sequence-specific targeting and covalent modification of human genomic DNA. Nucleic Acids Res (1997) 0.80
Letter: A new class of potent guanine antimetabolites. Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors. J Am Chem Soc (1975) 0.80
Minor groove DNA alkylation directed by major groove triplex forming oligodeoxyribonucleotides. Nucleic Acids Res (1997) 0.80
Linkers designed to intercalate the double helix greatly facilitate DNA alkylation by triplex-forming oligonucleotides carrying a cyclopropapyrroloindole reactive moiety. Nucleic Acids Res (1999) 0.80
Synthesis of fused [1,2,6]thiadiazine 1,1-dioxides as potential transition-state analogue inhibitors of xanthine oxidase and guanase. J Med Chem (1979) 0.80
Inhibitors of inosinic acid dehydrogenase. 2-Substituted inosinic acids. J Med Chem (1984) 0.79
Inhibition of inosinic acid dehydrogenase by 8-substituted purine nucleotides. J Med Chem (1981) 0.78
Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3. J Pharm Sci (1967) 0.78
Enhancement of interferon antiviral action in L-cells by cyclic nucleotides. Proc Soc Exp Biol Med (1974) 0.78
A new strategy of discrimination of a point mutation by tandem of short oligonucleotides. Nucleosides Nucleotides Nucleic Acids (2001) 0.78
Sequence-specific chemical modification of a hybrid bacteriophage M13 single-stranded DNA by alkylating oligonucleotide derivatives. FEBS Lett (1988) 0.78
Effect of modification of the 1-, 2-, and 6-positions of 9-beta-D-ribofuranosylpurine cyclic 3',5'-phosphate on the cyclic nucleotide specificity of adenosine cyclic 3',5'-phosphate- and guanosine cyclic 3',5'-phosphate-dependent protein kinases. Biochem Pharmacol (1981) 0.77
Pyridine nucleosides related to 5-fluorouracil and thymine. J Med Chem (1973) 0.77
Modulation of Cm/T, G/A, and G/T triplex stability by conjugate groups in the presence and absence of KCl. Biochemistry (1997) 0.77
Synthesis of some 1, 8- and 2, 8-disubstituted derivatives of adenosine cyclic 3', 5'-phosphate and their interaction with some enzymes of cAMP metabolism. J Med Chem (1976) 0.77
Mechanism of benzo[a]pyrene diol epoxide induced deoxyribonucleic acid strand scission. Biochemistry (1980) 0.76
Synthesis and enzymic studies of 5-aminoimidazole and N-1-and N6-substituted adenine ribonucleoside cyclic 3',5'-phosphates prepared from adenosine cyclic 3',5'-phosphate. J Med Chem (1973) 0.76
Targeted mutagenesis of DNA with alkylating RecA assisted oligonucleotides. Nucleic Acids Res (1999) 0.75
Irreversible enzyme inhibitors. CLIV. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-substituted 2,4-diaminopyrimidines. J Med Chem (1969) 0.75
[Diagnostic significance of so-called Veraguth's upper lid folds in depressions]. Schweiz Arch Neurol Neurochir Psychiatr (1970) 0.75
[Selective stabilization of AT-rich DNA duplexes by oligodeoxyribonucleotide conjugates with distamycin analogues]. Bioorg Khim (1997) 0.75
Structure-activity relationships of cytotoxic cholesterol-modified DNA duplexes. J Med Chem (1995) 0.75
Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride. J Med Chem (1969) 0.75
Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse. J Med Chem (1969) 0.75